Zhejiang Medicine Co (SHSE:600216) Cyclically Adjusted Book per Share: ¥9.37 (As of Mar. 2026)


SHSE:600216 Zhejiang Medicine Co Ltd SHSE:600216
81 GF Score
Price ¥12.00
GF Value ¥13.81
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Zhejiang Medicine Co Cyclically Adjusted Book per Share?

Zhejiang Medicine Co SHSE:600216 -0.83% 81 Cyclically Adjusted Book per Share is ¥9.37 as of Mar. 2026. GuruFocus rates SHSE:600216 with a GF Score™ of 81/100 and a GF Value™ of ¥13.81 (Modestly Undervalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Zhejiang Medicine Co's adjusted book value per share for the three months ended in Mar. 2026 was ¥11.689. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥9.37 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Zhejiang Medicine Co's average Cyclically Adjusted Book Growth Rate was 4.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 3.10% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 3.40% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 6.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Zhejiang Medicine Co was 29.80% per year. The lowest was 3.00% per year. And the median was 12.10% per year.

As of today (2026-07-08), Zhejiang Medicine Co's current stock price is ¥12.00. Zhejiang Medicine Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ¥9.37. Zhejiang Medicine Co's Cyclically Adjusted PB Ratio of today is 1.28.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Zhejiang Medicine Co was 2.93. The lowest was 1.01. And the median was 1.75.


Zhejiang Medicine Co  (SHSE:600216) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Zhejiang Medicine Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=12.00/9.37
=1.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Zhejiang Medicine Co was 2.93. The lowest was 1.01. And the median was 1.75.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Zhejiang Medicine Co Cyclically Adjusted Book per Share Related Terms


Zhejiang Medicine Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Zhejiang Medicine Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Medicine Co Cyclically Adjusted Book per Share Chart

Zhejiang Medicine Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.09 8.43 8.58 8.83 9.24

Zhejiang Medicine Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.93 9.00 9.13 9.24 9.37

SHSE:600216 vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Medicine Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Medicine Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Medicine Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Zhejiang Medicine Co's Cyclically Adjusted PB Ratio falls into.


SHSE:600216
81GF Score
Zhejiang Medicine Co Ltd SHSE:600216
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Medicine Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zhejiang Medicine Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=11.689/116.3033*116.3033
=11.689

Current CPI (Mar. 2026) = 116.3033.

Zhejiang Medicine Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 7.125 101.400 8.172
201609 7.173 102.400 8.147
201612 7.247 102.600 8.215
201703 7.298 103.200 8.225
201706 7.235 103.100 8.162
201709 7.251 104.100 8.101
201712 7.549 104.500 8.402
201803 8.059 105.300 8.901
201806 7.987 104.900 8.855
201809 8.006 106.600 8.735
201812 7.922 106.500 8.651
201903 8.005 107.700 8.644
201906 8.015 107.700 8.655
201909 8.100 109.800 8.580
201912 8.145 111.200 8.519
202003 8.299 112.300 8.595
202006 7.595 110.400 8.001
202009 7.788 111.700 8.109
202012 7.952 111.500 8.295
202103 8.235 112.662 8.501
202106 8.513 111.769 8.858
202109 8.762 112.215 9.081
202112 9.096 113.108 9.353
202203 9.369 114.335 9.530
202206 9.190 114.558 9.330
202209 9.497 115.339 9.576
202212 9.594 115.116 9.693
202303 9.741 115.116 9.842
202306 10.000 114.558 10.152
202309 9.859 115.339 9.941
202312 9.980 114.781 10.112
202403 10.127 115.227 10.222
202406 10.344 114.781 10.481
202409 10.754 115.785 10.802
202412 11.073 114.893 11.209
202503 11.509 115.116 11.628
202506 11.662 114.907 11.804
202509 11.496 115.471 11.579
202512 11.380 115.832 11.426
202603 11.689 116.303 11.689

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ¥9.37 mean?
Zhejiang Medicine Co (SHSE:600216) has a Cyclically Adjusted Book per Share of ¥9.37 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Zhejiang Medicine Co and its competitors.
Is Zhejiang Medicine Co's Cyclically Adjusted Book per Share too high?
Zhejiang Medicine Co's current Cyclically Adjusted Book per Share is ¥9.37. Overall, Zhejiang Medicine Co has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Medicine Co's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Zhejiang Medicine Co's Cyclically Adjusted Book per Share of ¥9.37 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Zhejiang Medicine Co and its competitors. Zhejiang Medicine Co's current Cyclically Adjusted Book per Share is ¥9.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Medicine Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Medicine Co (SHSE:600216) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥13.81, compared to a current price of ¥12.00 — trading 13.1% below its estimated fair value. The current Cyclically Adjusted Book per Share is ¥9.37. Zhejiang Medicine Co's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Zhejiang Medicine Co (SHSE:600216), the current Cyclically Adjusted Book per Share is ¥9.37 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhejiang Medicine Co (SHSE:600216) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Medicine Co stock appears to be undervalued. The current stock price of ¥12.00 is trading 13.1% below its estimated GF Value™ of ¥13.81. GuruFocus considers Zhejiang Medicine Co to be Modestly Undervalued.

Key valuation signals for SHSE:600216:

  • Cyclically Adjusted Book per Share: ¥9.37
  • GF Value™: ¥13.81 vs. price of ¥12.00 (13.1% below fair value)
  • GF Score™: 81/100 with 6 warning signs

No single metric tells the full story. See the SHSE:600216 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zhejiang Medicine Co Business Description

Address Comprehensive Building, No. 398 Mahuan Road, 3rd Floor, Building A, Binhai New City, Shaoxing, CHN, 312366
Zhejiang Medicine Co Ltd is a china-based pharmaceutical company. The company manufactures fat-soluble vitamins, vitamins, quinolones, and antibiotic-resistant antibiotics, vitamin E, natural vitamin E, beta-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin.
81GF Score

Get the complete analysis for SHSE:600216

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥12.00
Price
¥13.81
GF Value